The cytokinin-active ribonucleosides present in tRNA from etiolated Phaseolus vulgari L. seedlings have been isolated and identified as cisribosylzeatin, 2-methylthio-ribosylzeatin, and N_-(A2-isopentenyl)-adenosine. The structures of the compounds were established on the basis of their chromatographic properties and the mass spectra of their permethylated and perdeuteromethylated derivatives. Cis-ribosylzeatin was the major cytokinin-active constituent of tRNA from this source. plant tissue.
plant tissue.
We report here the isolation and identification of the cytokinins present in tRNA from etiolated Phaseolus vulgaris L. seedlings.
Our examination of this material was motivated, in part, by reports that dihydrozeatin occurs as a free cytokinin in P. vulgaris (23, 28) . This compound has not yet been demonstrated to occur in tRNA (4), and it was of interest to determine whether it might be present in P. vulgaris tRNA. We were also interested in examining the relative abundance of various cytokinin moieties in tRNA from an etiolated plant source.
Modified adenosine derivatives that bear N6-isoprenoid side chains and are cytokinin-active occur in the tRNA of virtually all organisms that have been examined to date (12, 20, 22) . The cytokinin-active ribonucleosides that have been identified as constituents of tRNA molecules include i6Ado,5 io6Ado and the 2-methylthio derivatives of these two compounds, ms2i6Ado and ms2io6Ado (12, 20, 22) . All four of these ribonucleosides occur in tRNA from plant sources (5, 6, 13, 26) , although ms2i6Ado is typically present in trace amounts, if at all. Trace amounts of the trans isomers of io6Ado and ms2io6Ado have also been reported to occur in plant tRNA preparations (2, (25) (26) (27) . The relative amounts of the different types of cytokinin moieties found in plant tRNA preparations vary with the source of the tRNA. The available evidence suggests that ms2i6Ado and ms2io6Ado are of organelle origin (7-10, 14, 24, 27) . Thus, the variability in the cytokinin constituents of plant tRNA preparations may be related to differences in the abundance of organelle tRNA species in particular ' Isolation and Cytokinin-Active Ribonucleosides from Phaseokus tRNA. Phaseolus tRNA (6,070 A260 units) was hydrolyzed to nucleosides by treatment with ribonuclease Tl followed by snake venom phosphodiesterase and alkaline phosphatase as described by Murai et al. (19) . The hydrolysate was adjusted to pH 7.5 and two volumes of ethanol were added. The small amount of precipitate that formed was removed by centrifugation (3,000g, 10 min), and the supernatant liquid was evaporated to dryness under reduced pressure at 37 C in a silanized evaporating flask. Silanized glassware, prepared by treatment with 5% (v/v) dichlorodimethylsilane in benzene, was used in all subsequent steps of the isolation procedure. The dry solids recovered from the tRNA hydrolysate were fractionated according to the procedure of Armstrong et al.
(1).
The solids were extracted six times (15 min each) with watersaturated ethyl acetate (30 ml per extraction). The extracts were combined and evaporated to dryness as described above. The ethyl acetate-soluble nucleosides thus obtained were fractionated by Sephadex LH-20 column chromatography as described in the text. Fractions from the Sephadex LH-20 column eluates were pooled on the basis of the elution positions of authentic cytokinin standards chromatographed on the same columns after the elution of the tRNA nucleosides. Aliquots of the pooled fractions were bioassayed for cytokinin activity as described below. The remainder of each pooled fraction was taken to dryness under reduced pressure at 37 C, and the solids recovered from cytokinin-active fractions were used for the identification of cytokinin-active ribonucleosides.
Identification of Cytokinin-Active Ribonucleosides. The compositions of the cytokinin-active fractions recovered from the Sephadex LH-20 columns were examined by high performance liquid chromatography using a Waters ALC 202 System equipped with two model 600 pumps and a model 660 Solvent Programmer (Waters Associates, Milford, MA). Samples consisting of 1% of the cytokinin-active fractions were applied to a 2.1 x 250 mm ,uBondapak C18 column (Waters Associates) equilibrated with 20 mM ammonium acetate (pH 3.5). The column was eluted with a linear ethanol gradient (0-70%, v/v, in the ammonium acetate buffer) over 18 min at a flow rate of 1.5 ml/min. The HPLC chromatograms of the samples were compared to similar chromatograms of authentic cytokinins and their ribonucleosides.
GC-MS analysis was performed with a Varian 1200 Gas-Liquid Chromatograph interfaced with a Varian MAT CH7 Mass Spectrometer via a single-stage glass jet separator. Data acquisition from this system was by means of an on-line System 150/PDP-8 computer (System Industries, Sunnyvale, CA). Samples consisting of 70%Yo of the cytokinin-active materials recovered from the Sephadex LH-20 column fractions were permethylated by a modification of the method of Hakomori (11) as described by KaissChapman (15) . The remainder of the cytokinin-active material from each fraction was perdeuteromethylated in the same manner. The derivatized samples were introduced into the GC-MS system by injection into a capillary glass column (0.5 mm x 20 m) coated ,with a solution containing 8 mg/ml Dexsil 300 (Analabs, Inc., North Haven, CT) and I mg/ml Silanox 101 (Cabot Corp., Boston, MA) in chloroform. The temperature was held at 200 C for 5 min following sample injection and then raised to 325 C at a rate of 6 C/min. Helium was used as the carrier gas at linear flow rate of 30 cm/s. Approximately one-sixth of the column effluent was diverted to the flame ionization detector of the gas chromatograph. The mass spectra of suspected cytokinin ribonucleosides were compared with mass spectra of authentic cytokinin ribonucleosides obtained in the same manner.
Determination of Cytokinin Activity. Aliquot parts (200%o) of the pooled fractions from Sephadex LH-20 column eluates were tested for cytokinin activity in the tobacco callus bioassay (18) . The bioassay samples were evaporated to dryness under reduced pressure at 37 C and acid-hydrolyzed in 5 ml 0.1 N HCI (100 C, 45 min) prior to bioassay. The neutralized hydrolysates were incorporated into 100 ml RM-1965 medium containing 2 mg/l indole-3-acetic acid and tested in 5-fold serial dilutions in the tobacco bioassay as described by Armstrong et al. Fig. 1 were dissolved in 5 ml distilled H20 and rechromatographed on a Sephadex LH-20 column (2 x 60 cm) in distilled H20. Fractions were pooled as indicated and aliquots of the pooled fractions tested for cytokinin activity in tobacco bioassay as described. The elution position of authentic iotAdo is indicated. RETENTION TIME (minutes) FIG. 3 . HPLC analysis of the cytokinin-active nucleosides from P. vulgaris tRNA. A, cytokinin standards; B, nucleosides from fraction 1114 (Fig. 2) ; C, nucleosides from fraction V (Fig. 1) . Details of chromatographic procedures are described under "Materials and Methods."
peaks. The first peak exhibited a retention time intermediate between that of the f6Ade and i6Ado standards. Subsequent work has established that this elution position corresponds to that of ms2io6Ado (isomers not resolved). The second peak exhibited a retention time identical with that of authentic i6Ado.
The presence of cis-io6Ado in fraction II14 and ms2io6Ado and i6Ado in fraction V was confirmed by GC-MS analysis of the permethylated and perdeuteromethylated derivatives of the solids recovered from these fractions. The permethyl derivatives of these compounds exhibited mass spectra and GC retention times identical with those previously published (8, 15, 16 The small amount of cytokinin activity eluting in fraction III-3 (Fig. 2) of the Sephadex LH-20 fractionation has also been examined. The results of GC-MS analysis indicated that this activity was derived from the adjacent, main cis-io6Ado peak. No fragment ions corresponding to those of authentic ribosyldihydrozeatin were detected in either fraction III-3 or fraction III-4.
DISCUSSION
The cytokinin-active ribonucleosides present in tRNA from etiolated P. vulgaris seedlings have been identified as cis-io6Ado, i6Ado, and ms io6Ado (isomer distribution not determined). No cytokinin activity corresponding to the expected elution position of ms2i6Ado was detected in the Sephadex LH-20 fractionation of the ethyl acetate-soluble nucleosides from the tRNA preparation used here. cis-Ribosylzeatin was the predominant cytokinin active ribonucleoside present in the tRNA preparation. Based on computer integration of peak areas from the GC chromatograms, the recovery of cytokinin moieties from the tRNA preparation was equivalent to 22.4 nmol io6Ado, 3.4 nmol ms2io6Ado, and 3.6 nmol i6Ado/ 1,000 A260 units tRNA.
Dihydrozeatin has been reported to be a major component of the free cytokinins in P. vulgaris (7, 28 ), but we were unable to detect ribosyldihydrozeatin in the tRNA from the etiolated P. vulgaris seedlings. Similarly, Burrows (4) was unable to find evidence for the presence of this compound in tRNA from seeds of Lupinus luteus L., where is also occurs as a free cytokinin (17) . The available evidence suggests that reduction of the isoprenoid side chain of cytokinin residues does not occur in tRNA, although tRNA preparations from green tissues of appropriate plant species have not yet been examined.
The presence of only small quantities of ms2io6Ado and i6Ado in the tRNA preparation and the apparent absence of ms2i6Ado are probably related to the use of etiolated material. The latter compound (ms2i6Ado) has been identified as a constituent of chloroplast tRNAPhe from P. vulgaris (9, 10) , and it also occurs as a constituent of chloroplast tRNAPhe in Euglena (7, 14) . Swaminathan et al. (24) have reported that ms2io6Ado is absent from the tRNA of both dark-grown and chloroplast-bleached mutants of Euglena, and Vreman et al. (27) found ms2io6Ado and i6Ado to be the only detectable cytokinin-active ribonucleosides in chloroplast tRNA preparations from spinach leaves. Therefore, the methylthiolation of cytokinin residues in tRNA may be restricted to organelle tRNA populations in eukaryotic cells. 
